{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:54:00Z","timestamp":1759776840320,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bpc.2020.106511","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T20:42:24Z","timestamp":1606509744000},"page":"106511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Expression, purification and characterisation of large quantities of recombinant human IAPP for mechanistic studies"],"prefix":"10.1016","volume":"269","author":[{"given":"Martin","family":"Lundqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana C.","family":"Rodriguez Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Bernfur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Linse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"Mehnert, H., Typ-2-Diabetes Vol. 2., erw. Aufl. 2000, M\u00fcnchen: Medikon.","key":"10.1016\/j.bpc.2020.106511_bb0005","DOI":"10.1007\/978-3-642-59754-1_20"},{"issue":"S5","key":"10.1016\/j.bpc.2020.106511_bb0010","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.0.CO;2-R","article-title":"The rising global burden of diabetes and its complications: estimates and projections to the year 2010","volume":"14","author":"Amos","year":"1997","journal-title":"Diabet. Med."},{"author":"Federation","key":"10.1016\/j.bpc.2020.106511_bb0015"},{"issue":"12","key":"10.1016\/j.bpc.2020.106511_bb0020","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00125-004-1577-2","article-title":"Common polymorphisms of the PPAR-\u03b32 (Pro12Ala) and PGC-1\u03b1 (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial","volume":"47","author":"Andrulionyte","year":"2004","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.bpc.2020.106511_bb0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1464-5491.2005.01550.x","article-title":"Genetics of type 2 diabetes","volume":"22","author":"Barroso","year":"2005","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.bpc.2020.106511_bb0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2337\/dc08-2171","article-title":"Genetic architecture of type 2 diabetes: recent progress and clinical implications","volume":"32","author":"Grant","year":"2009","journal-title":"Diabetes Care"},{"issue":"31","key":"10.1016\/j.bpc.2020.106511_bb0035","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1021\/bi060579z","article-title":"Conserved and cooperative assembly of membrane-bound \u03b1-helical states of islet amyloid polypeptide","volume":"45","author":"Knight","year":"2006","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bpc.2020.106511_bb0040","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.bpj.2009.08.041","article-title":"Evidence for a partially structured state of the amylin monomer","volume":"97","author":"Vaiana","year":"2009","journal-title":"Biophys. J."},{"issue":"4","key":"10.1016\/j.bpc.2020.106511_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","article-title":"On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus","volume":"5","author":"Opie","year":"1901","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bpc.2020.106511_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00253746","article-title":"Isolation and characterisation of insulin secretory granules from a rat islet cell tumour","volume":"23","author":"Hutton","year":"1982","journal-title":"Diabetologia"},{"issue":"23","key":"10.1016\/j.bpc.2020.106511_bb0055","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.bpc.2020.106511_bb0060","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2020.106511_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bpc.2020.106511_bb0070","series-title":"Human Disease: A Summary of Progress Over the Last Decade, in Annual Review of Biochemistry","first-page":"27","volume":"Vol 86","author":"Chiti","year":"2017"},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2003.12.008","article-title":"Principles of protein folding, misfolding and aggregation","volume":"15","author":"Dobson","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bpc.2020.106511_bb0080","first-page":"12(2)","article-title":"The Amyloid Phenomenon and Its Significance in Biology and Medicine","author":"Dobson","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"15","key":"10.1016\/j.bpc.2020.106511_bb0085","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1039\/C9CS00199A","article-title":"Half a century of amyloids: past, present and future","volume":"49","author":"Ke","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.bpc.2020.106511_bb0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.bpc.2020.106511_bb0095","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1111\/j.1742-4658.2005.05024.x","article-title":"Aspects on human amyloid forms and their fibril polypeptides","volume":"272","author":"Westermark","year":"2005","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506120500032196","article-title":"Amyloid: toward terminology clarification report from the nomenclature Committee of the International Society of amyloidosis","volume":"12","author":"Westermark","year":"2005","journal-title":"Amyloid"},{"issue":"7","key":"10.1016\/j.bpc.2020.106511_bb0105","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1073\/pnas.96.7.3590","article-title":"Designing conditions for <em>in vitro<\/em> formation of amyloid protofilaments and fibrils","volume":"96","author":"Chiti","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.bpc.2020.106511_bb0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","article-title":"Protein misfolding, evolution and disease","volume":"24","author":"Dobson","year":"1999","journal-title":"Trends Biochem. Sci."},{"issue":"24","key":"10.1016\/j.bpc.2020.106511_bb0115","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta 42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2\u20133","key":"10.1016\/j.bpc.2020.106511_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmb.2012.02.031","article-title":"From macroscopic measurements to microscopic mechanisms of protein aggregation","volume":"421","author":"Cohen","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2020.106511_bb0125","doi-asserted-by":"crossref","DOI":"10.1017\/S0033583516000172","article-title":"Secondary nucleation of monomers on fibril surface dominates alpha-synuclein aggregation and provides autocatalytic amyloid amplification","volume":"50","author":"Gaspar","year":"2017","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.bpc.2020.106511_bb0130","series-title":"Protein Misfolding Diseases","first-page":"1069","author":"Abedini","year":"2010"},{"issue":"2","key":"10.1016\/j.bpc.2020.106511_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0140","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/jme.0.003R001","article-title":"Expression of the rat amylin (IAPP\/DAP) gene","volume":"3","author":"Ferrier","year":"1989","journal-title":"J. Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0169-328X(98)00269-1","article-title":"Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice","volume":"63","author":"Gebre-Medhin","year":"1998","journal-title":"Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.bpc.2020.106511_bb0150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0196-9781(97)00008-9","article-title":"Islet amyloid polypeptide in the gut and pancreas: localization, ontogeny and gut motility effects","volume":"18","author":"Mulder","year":"1997","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.bpc.2020.106511_bb0155","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1523\/JNEUROSCI.15-11-07625.1995","article-title":"Islet amyloid polypeptide (amylin) is expressed in sensory neurons","volume":"15","author":"Mulder","year":"1995","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.bpc.2020.106511_bb0160","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","article-title":"The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells","volume":"273","author":"Konarkowska","year":"2006","journal-title":"FEBS J."},{"issue":"17","key":"10.1016\/j.bpc.2020.106511_bb0165","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.1074\/jbc.M115.712455","article-title":"Differential activation of innate immune pathways by distinct islet amyloid polypeptide (IAPP) aggregates","volume":"291","author":"Westwell-Roper","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2020.106511_bb0170","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1042\/BCJ20170323","article-title":"Recombinant human islet amyloid polypeptide forms shorter fibrils and mediates beta-cell apoptosis via generation of oxidative stress","volume":"474","author":"Dubey","year":"2017","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bpc.2020.106511_bb0180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","article-title":"Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus","volume":"183","author":"Betsholtz","year":"1989","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bpc.2020.106511_bb0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/bj2450575","article-title":"The insulin-secretory-granule carboxypeptidase H. purification and demonstration of involvement in proinsulin processing","volume":"245","author":"Davidson","year":"1987","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.bpc.2020.106511_bb0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00265542","article-title":"The insulin secretory granule","volume":"32","author":"Hutton","year":"1989","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0014-5793(89)81260-8","article-title":"The complete islet amyloid polypeptide precursor is encoded by two exons","volume":"247","author":"Mosselman","year":"1989","journal-title":"FEBS Lett."},{"issue":"15","key":"10.1016\/j.bpc.2020.106511_bb0200","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1073\/pnas.86.15.5738","article-title":"Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone","volume":"86","author":"Nishi","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"33","key":"10.1016\/j.bpc.2020.106511_bb0205","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1016\/S0021-9258(19)77825-9","article-title":"An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing","volume":"263","author":"Sanke","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bpc.2020.106511_bb0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.bpc.2020.106511_bb0215","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/acs.biochem.8b00017","article-title":"Analysis of the role of the conserved Disulfide in amyloid Formation by human islet amyloid polypeptide in homogeneous and heterogeneous environments","volume":"57","author":"Ridgway","year":"2018","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.sbi.2012.11.003","article-title":"Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology","volume":"23","author":"Cao","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"37","key":"10.1016\/j.bpc.2020.106511_bb0225","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bpc.2020.106511_bb0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0959-440X(98)80037-7","article-title":"The role of assembly in insulin\u2019s biosynthesis","volume":"8","author":"Dodson","year":"1998","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bpc.2020.106511_bb0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj2040171","article-title":"The internal pH and membrane potential of the insulin-secretory granule","volume":"204","author":"Hutton","year":"1982","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bpc.2020.106511_bb0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(95)01512-4","article-title":"Effects of beta cell granule components on human islet amyloid polypeptide fibril formation","volume":"379","author":"Westermark","year":"1996","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bpc.2020.106511_bb0245","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pro.145","article-title":"Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process","volume":"18","author":"Wiltzius","year":"2009","journal-title":"Protein Sci."},{"issue":"14","key":"10.1016\/j.bpc.2020.106511_bb0250","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1021\/bi0160462","article-title":"Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis","volume":"41","author":"Padrick","year":"2002","journal-title":"Biochemistry"},{"issue":"30","key":"10.1016\/j.bpc.2020.106511_bb0255","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1073\/pnas.0703306104","article-title":"Fiber-dependent amyloid formation as catalysis of an existing reaction pathway","volume":"104","author":"Ruschak","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2020.106511_bb0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pep.2014.04.002","article-title":"Preparation of uniformly C-13,N-15-labeled recombinant human amylin for solid-state NMR investigation","volume":"99","author":"Kosicka","year":"2014","journal-title":"Protein Expr. Purif."},{"issue":"41","key":"10.1016\/j.bpc.2020.106511_bb0265","doi-asserted-by":"crossref","first-page":"42803","DOI":"10.1074\/jbc.M406108200","article-title":"Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP)","volume":"279","author":"Lopes","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"Supplement C","key":"10.1016\/j.bpc.2020.106511_bb0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jbiotec.2014.06.006","article-title":"Engineered aggregation inhibitor fusion for production of highly amyloidogenic human islet amyloid polypeptide","volume":"191","author":"Mirecka","year":"2014","journal-title":"Journal of Biotechnology"},{"key":"10.1016\/j.bpc.2020.106511_bb0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pep.2014.10.012","article-title":"Cloning, expression and purification of the human islet amyloid polypeptide (hIAPP) from Escherichia coli","volume":"106","author":"Rodriguez Camargo","year":"2015","journal-title":"Protein Expr. Purif."},{"issue":"3","key":"10.1016\/j.bpc.2020.106511_bb0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0167-4889(89)90220-6","article-title":"Amylin and the amylin gene - structure, function and relationship to islet amyloid and to diabetes-mellitus","volume":"1014","author":"Cooper","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.bpc.2020.106511_bb0285","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","article-title":"Molecular and functional-characterization of amylin, a peptide associated with TYPE-2 diabetes-mellitus","volume":"86","author":"Roberts","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bpc.2020.106511_bb0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nprot.2016.010","article-title":"Molecular mechanisms of protein aggregation from global fitting of kinetic models","volume":"11","author":"Meisl","year":"2016","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.bpc.2020.106511_bb0295","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","article-title":"A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid beta-peptide","volume":"276","author":"Walsh","year":"2009","journal-title":"FEBS J."},{"issue":"16","key":"10.1016\/j.bpc.2020.106511_bb0300","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.1219059110","article-title":"Common mechanism unites membrane poration by amyloid and antimicrobial peptides","volume":"110","author":"Last","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6473","key":"10.1016\/j.bpc.2020.106511_bb0305","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"issue":"52","key":"10.1016\/j.bpc.2020.106511_bb0310","doi-asserted-by":"crossref","first-page":"52810","DOI":"10.1074\/jbc.M308244200","article-title":"Fibrillogenic amylin evokes islet \u03b2-cell apoptosis through linked activation of a caspase Cascade and JNK1","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bpc.2020.106511_bb0315","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-5793(99)00894-7","article-title":"Induction of apoptosis by human amylin in RINm5F islet \u03b2-cells is associated with enhanced expression of p53 and p21WAF1\/CIP1","volume":"455","author":"Zhang","year":"1999","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.bpc.2020.106511_bb0320","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.72.3.2544-2547.1998","article-title":"N-terminal protease of pestiviruses: identification of putative catalytic residues by site-directed mutagenesis","volume":"72","author":"R\u00fcmenapf","year":"1998","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.bpc.2020.106511_bb0325","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/bit.22432","article-title":"Refolding of N-pro fusion proteins","volume":"104","author":"Kaar","year":"2009","journal-title":"Biotechnol. Bioeng."},{"issue":"7","key":"10.1016\/j.bpc.2020.106511_bb0330","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"46","key":"10.1016\/j.bpc.2020.106511_bb0335","doi-asserted-by":"crossref","first-page":"16748","DOI":"10.1021\/jacs.7b08830","article-title":"A free energy barrier caused by the refolding of an oligomeric intermediate controls the lag time of amyloid Formation by hIAPP","volume":"139","author":"Serrano","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/cn900015v","article-title":"Amyloid beta-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process","volume":"1","author":"Hellstrand","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"21","key":"10.1016\/j.bpc.2020.106511_bb0345","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bpc.2020.106511_bb0350","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1038\/ncomms10948","article-title":"Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation","volume":"7","author":"Arosio","year":"2016","journal-title":"Nat. Commun."},{"doi-asserted-by":"crossref","unstructured":"Cabaleiro-Lago et al. Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles. Langmuir 2010. 26(5): p. 3453\u20133461.","key":"10.1016\/j.bpc.2020.106511_bb0355","DOI":"10.1021\/la902980d"}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462220302192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462220302192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:58:08Z","timestamp":1759564688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462220302192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":71,"alternative-id":["S0301462220302192"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2020.106511","relation":{},"ISSN":["0301-4622"],"issn-type":[{"type":"print","value":"0301-4622"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression, purification and characterisation of large quantities of recombinant human IAPP for mechanistic studies","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2020.106511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106511"}}